Artificial intelligence for cancer-associated thrombosis risk assessment
- 1 September 2018
- journal article
- letter
- Published by Elsevier in The Lancet Haematology
- Vol. 5 (9) , e391-E391
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Simplicity versus complexity: an existential dilemma as risk tools evolveThe Lancet Haematology, 2018
- A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohortsThe Lancet Haematology, 2018
- Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in OncologyDisease Markers, 2017
- –Omic and Electronic Health Record Big Data Analytics for Precision MedicineIEEE Transactions on Biomedical Engineering, 2016
- Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosisThrombosis Research, 2015